BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25686830)

  • 21. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma.
    de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO
    J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation.
    Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B
    Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
    Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
    J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
    Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
    Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma.
    Ogawa T; Ogawa K; Shiga K; Furukawa T; Nagase H; Hashimoto S; Kobayashi T; Horii A
    Eur Arch Otorhinolaryngol; 2010 Oct; 267(10):1599-606. PubMed ID: 20443017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
    Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1115-22. PubMed ID: 19280190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
    Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
    BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Insight into the role of IGF2BP1 in drug resistant mechanism of oral squamous cell carcinoma].
    Xie F; Qin X; Tong T; Jiang YY; Zhang JJ
    Shanghai Kou Qiang Yi Xue; 2021 Oct; 30(5):456-461. PubMed ID: 34888594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-222 targeted PUMA to improve sensitization of UM1 cells to cisplatin.
    Jiang F; Zhao W; Zhou L; Liu Z; Li W; Yu D
    Int J Mol Sci; 2014 Dec; 15(12):22128-41. PubMed ID: 25474084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The scorpion venom peptide BmKn2 induces apoptosis in cancerous but not in normal human oral cells.
    Satitmanwiwat S; Changsangfa C; Khanuengthong A; Promthep K; Roytrakul S; Arpornsuwan T; Saikhun K; Sritanaudomchai H
    Biomed Pharmacother; 2016 Dec; 84():1042-1050. PubMed ID: 27780132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
    Suzuki M; Shinohara F; Nishimura K; Echigo S; Rikiishi H
    Int J Oncol; 2007 Dec; 31(6):1449-56. PubMed ID: 17982671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma.
    Jiffar T; Yilmaz T; Lee J; Hanna E; El-Naggar A; Yu D; Myers JN; Kupferman ME
    Oncogene; 2011 Jul; 30(28):3163-73. PubMed ID: 21383688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors.
    Han HY; Lee HE; Kim HJ; Jeong SH; Kim JH; Kim H; Ryu MH
    J Ethnopharmacol; 2016 Nov; 192():431-441. PubMed ID: 27616033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.
    Yamano Y; Uzawa K; Saito K; Nakashima D; Kasamatsu A; Koike H; Kouzu Y; Shinozuka K; Nakatani K; Negoro K; Fujita S; Tanzawa H
    Int J Cancer; 2010 Jan; 126(2):437-49. PubMed ID: 19569180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tigecycline exerts an antitumoral effect in oral squamous cell carcinoma.
    Ren A; Qiu Y; Cui H; Fu G
    Oral Dis; 2015 Jul; 21(5):558-64. PubMed ID: 25581076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
    Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
    J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.